app

Sugary Drinks Tied to 2M Diabetes Cases; Diagnosing LADA; Top GLP-1 for Weight Loss

— News and commentary from the endocrinology world

MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

A total of and 1.2 million new cardiovascular disease cases worldwide in 2020 were attributable to sugar-sweetened beverages. (Nature Medicine)

Former Endocrine Society President Teresa K. Woodruff, PhD, was one of the for her pioneering work in oncofertility. (Endocrine News)

In a trial of seniors with type 1 diabetes, decreased hypoglycemia compared with sensor-augmented pump delivery. (NEJM Evidence)

Mehmet Oz, MD, and Robert F. Kennedy Jr. -- tapped by President-elect Donald Trump for high-profile health roles -- have . (The Hill)

Looking to differentiate latent autoimmune diabetes in adults (LADA) from ? Try checking serum levels of autoantibodies against interferon-alpha isoforms. (Journal of Clinical Endocrinology & Metabolism)

Investigational once-weekly retatrutide yielded of all GLP-1 receptor agonists, up to 22.1% after 48 weeks in adults with overweight or obesity and without diabetes, according to a review of 26 randomized trials. (Annals of Internal Medicine)

Eli Lilly filed by compounding pharmacies against the FDA over the agency's decision that Lilly's weight-loss and diabetes drugs are no longer in short supply. (Reuters via CNBC)

Older Chinese adults with type 2 diabetes if their spouse engaged in an educational intervention with them. (JAMA Network Open)

Patients on GLP-1 agonists may to receive the best care. (STAT)

Acelyrin said its investigational drug lonigutamab for thyroid eye disease is .

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.